Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec;16(12):1840-3.
doi: 10.1128/CVI.00238-09. Epub 2009 Oct 14.

Prevalence of human papillomavirus 16 and 18 neutralizing antibodies in prenatal women in British Columbia

Mel Krajden  1 , Karuna Karunakaran, Stacy So, Joel M Palefsky, Rachna Sharma, Darrel Cook, Amanda Yu, Ron Chow, Simon Dobson, Gina S Ogilvie, Martin Petric
Affiliations

Prevalence of human papillomavirus 16 and 18 neutralizing antibodies in prenatal women in British Columbia

Mel Krajden et al. Clin Vaccine Immunol. 2009 Dec.

Abstract

Human papillomavirus (HPV) type 16 and 18 neutralizing antibody (NAb) titers were measured in 1,020 prenatal women in British Columbia aged 15 to 39. HPV 16 and 18 NAbs were detected in 183/1,020 (17.9%) and 97/1,020 (9.5%), respectively, and 39 (3.8%) had NAbs to both types. Titers were similar across age strata.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Age distribution of HPV 16 and 18 neutralizing antibodies in prenatal women in BC (n = 1,020).
FIG. 2.
FIG. 2.
Age-stratified HPV 16 and 18 neutralizing antibody GMTs in prenatal women in BC.
See this image and copyright information in PMC

References

    1. Buck, C. B., D. V. Pastrana, D. R. Lowy, and J. T. Schiller. 2005. Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods Mol. Med. 119:445-462. - PubMed
    1. Carter, J. J., L. A. Koutsky, J. P. Hughes, S. K. Lee, J. Kuypers, N. Kiviat, and D. A. Galloway. 2000. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J. Infect. Dis. 181:1911-1919. - PubMed
    1. Dessy, F. J., S. L. Giannini, C. A. Bougelet, T. J. Kemp, M.-P. M. David, S. M. Poncelet, L. A. Pinto, and M. A. Wettendorff. 2008. Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the ASO4-adjuvanted HPV-16/18 cervical cancer vaccine. Hum. Vaccin. 4:425-434. - PubMed
    1. Ferguson, M., A. Heath, S. Johnes, S. Pagliusi, J. Dillner, et al. 2006. Results of the first W. H. O. international collaborative study on the standardization of the detection of antibodies to human papillomaviruses. Int. J. Cancer 118:1508-1514. - PubMed
    1. Ferguson, M., D. E. Wilkinson, and T. Zhou. 2009. W. H. O. meeting on the standardization of HPV assays and the role of the W. H. O. HPV Laboratory Network in supporting vaccine introduction held on 24-25 January 2008, Geneva, Switzerland. Vaccine 27:337-347. - PubMed

Publication types

MeSH terms